Cobra Biologics, Contract Manufacturing Excellence: Aseptic Pharmaceuticals Manufacture and Lyophilization

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Cobra Biologics
Microbiota Production and Fill Finish Facility (Matfors, Sweden) +46 60 785 86 00
Mammalian Production Facility (Södertälje, Sweden) +46 855 250 500
Cell and Gene Therapy Facility (Keele, UK) +44 1782 714 181
Email: [email protected]

Company website

Cobra Biologics is a leading international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.

Cobra has three GMP approved facilities in Sweden and the UK, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.

As a trusted provider and a key partner in the drug development and commercialization process, we take pride in our manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries.

Beyond "Disease X": Strategic R&D in an Era of Emerging Threats

10/30/2024 | Sponsored by Biosynth